Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics

International Journal of Medical Sciences

Volumn 9, Issue 5, 2012, Pages 380-386

  Wang, Hao ^a   Duan, Qianglin ^a   Wang, Lemin ^a   Gong, Zhu ^a   Liang, Aibin ^a   Wang, Qiang ^a   Song, Haoming ^a   Yang, Fan ^a   Song, Yanli ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Adhesion molecules; Human genomics; Pulmonary embolism (pe); T cell immunity

Indexed keywords

ANTICOAGULANT PROTEIN; BLOOD CLOTTING FACTOR; CELL ADHESION MOLECULE; FIBRINOLYTIC FACTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN GENOME; IMMUNE DEFICIENCY; LUNG EMBOLISM; MALE; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; THROMBOCYTE FUNCTION; UPREGULATION; VASCULAR ENDOTHELIUM; GENETICS; GENOMICS; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOMICS; HUMANS; MALE; MIDDLE AGED; PULMONARY EMBOLISM;

EID: 84868022190     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.4641     Document Type: Article

References (29)

1. Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence). Int Angiol 2006;25:101-161.
2. Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med 2008;168:425-430.
3. He J, Cheng X, Gao M. [Survey of diagnosis and treatment of acute pulmonary embolism in 21 hospitals in China]. Zhonghua Yi Xue Za Zhi 2001;81:1490-1492.
4. Sakuma M, Konno Y, Shirato K. Increasing mortality from pulmonary embolism in Japan, 1951-2000. Circ J 2002;66:1144-1149.
5. Palwatwichai A, Gaewtam-Manugul P, Apiratpracha W, Vattanathum A, Tantamacharik D, Wongsa A. Clinical and laboratory findings in patients with pulmonary embolism in Phramongkutklao Hospital. J Med Assoc Thai 2000;83:1463-1470.
6. Lee LH. Clinical update on deep vein thrombosis in Singapore. Ann Acad Med Singapore 2002;31:248-252.
7. Piovella F, Wang CJ, Lu H, Lee K, Lee LH, Lee WC, et al. Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost 2005;3:2664-2670.
8. Leizorovicz A. Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study. Haematologica 2007;92:1194-1200.
9. Raskob GE, Silverstein R, Bratzler DW, Heit JA, White RH. Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop. Am J Prev Med. 2010;38(4 Suppl):S502-509.
10. [Internet] Pulmonary Embolism. http://www.wrongdiagnosis.com/p/pulmonary_embolism/stats-country.htm
11. Hyers, TM. Venous thromboembolism. Am J Respir Crit Care Med 1999; 99: 1-14.
12. Tierney LM, McPhee SJ, Papadakis MA. Disorders of pulmonary circulation: pulmonary thromboembolism. Current Medical Diagnosis and Treatment 2000; 39: 321-330.
13. Virchow R. Gesammalte abhandlungen zur wissenschaftlichen medtzin. Frankfurt, Medinger: Sohn & Company. 1856.
14. Egeberg O. Inherited Antithrombin Deficiency Causing Thrombophilia. Thromb Diath Haemorrh 1965;13:516-530.
15. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001;109:369-384.
16. Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999;353:1167-1173.
17. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126:338-400.
18. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381-453.
19. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 1999;21:33-37.
20. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-470.
21. Rudert F. Genomics and proteomics tools for the clinic. Curr Opin Mol Ther 2000;2:633-642.
22. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-29.
23. Dupuy D, Bertin N, Hidalgo CA, Venkatesan K, Tu D, Lee D, et al. Genome-scale analysis of in vivo spatiotemporal promoter activity in Caenorhabditis elegans. Nat Biotechnol 2007; 25:663-668.
24. Vermeirssen V, Barrasa MI, Hidalgo CA, Babon JA, Sequerra R, Doucette-Stamm L, et al. Transcription factor modularity in a gene-centered C. elegans core neuronal protein-DNA interaction network. Genome Res 2007;17:1061-1071.
25. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000;355:1295-1302.
26. Haoming S, Lemin W, Zhu G, Aibin L, Yuan X, Wei L, et al. T cell-mediated immune deficiency or compromise in patients with CTEPH. Am J Respir Crit Care Med; 2011; 183:417-418.
27. Wang L, Song H, Gong Z, Duan Q, Liang A. Acute Pulmonary Embolism and Dysfunction of CD3+ CD8+ T Cell Immunity. Am J Respir Crit Care Med. 2011 184: 1315
28. Xiang-Hua Y, Le-Min W, Ai-Bin L, Zhu G, Riquan L, Xu-You Z, et al. Severe acute respiratory syndrome and venous thromboembolism in multiple organs. Am J Respir Crit Care Med. 2010;182(3):436-437.
29. Wang L, Gong Z, Jiang J, Xu W, Duan Q, Liu J, et al. Confusion of Wide Thrombolytic Time Window for Acute Pulmonary Embolism: Mass Spectrographic Analysis for Thrombus Proteins. Am J Respir Crit Care Med. 2011 184: 145-146.